Inhibition of Enzymatic Acetylation-Mediated Resistance to Plazomicin by Silver Ions
Sign Up to like & getrecommendations! Published in 2023 at "Pharmaceuticals"
DOI: 10.3390/ph16020236
Abstract: Plazomicin is a recent U.S. Food and Drug Administration (FDA)-approved semisynthetic aminoglycoside. Its structure consists of a sisomicin scaffold modified by adding a 2(S)-hydroxy aminobutyryl group at the N1 position and a hydroxyethyl substituent at… read more here.
Keywords: acetylation; mediated resistance; silver; plazomicin ... See more keywords